In the first two months of the financial year 2025–26, India’s pharma exports reached ₹4.96 billion – a major achievement for the industry. This growth clearly shows that people across the world trust Indian medicines, whether it is due to their pocket friendly pricing or their dependable quality. The global demand for generic medicines, vaccines and APIs is growing rapidly, which is having a direct impact on exports. Bulk orders are being received from regions like the USA, Africa, Europe and SouthEast Asia. Government support – such as the PLI scheme and strict quality control – has also given a boost to the pcd pharma franchise monopoly basis. Everyone is working together – and the result is that India is establishing its strong position on the world pharmaceutical stage.
India’s Drug Exports in May 2025: Growth, Numbers & Trends
1. Export Figure of May:
In the month of May 2025 alone, India exported pharma products worth $2.48 billion. This represents a growth of 7.38% compared to last year, which clearly shows that demand for the pharma sector is consistently strong — a positive signal for the industry.
2. April–May Combinate Total Data:
In April and May — just two months — exports crossed the $4.96 billion mark. An overall jump of 4.81% was seen in this short period, which proves that global demand for Indian medicines is not only stable but is also growing.
3. Most Exported Products:
Formulations and biologics topped the export list with a share of 75.7%. Also, bulk drugs recorded a growth of 4.4%, vaccines 13.6%, surgical products 8.6%, and Ayush/herbal items 7.4% — which clearly shows that each segment has its own strong demand base.
4. Major Export Countries:
USA was the top buyer (34.5% share) — approximately $1.71 billion. There was good growth in Europe and Africa too – 3.1% and 1.7%.
5. New & Strong Markets:
North America, Europe, Africa and Latin America held 76% of the market. ASEAN countries are also now becoming strong buyers (4.9% share).
6. Growth Reasons:
The reasons behind this growth are – Make in India quality, global demand, support of PLI scheme, and developments like India–UK FTA.
How Is India Making Pharma Exports Better?
These days the Indian pharma sector is tightening quality control, and there is a full focus on matching global standards and delivering on time. The government is also not behind – companies are getting solid support in increasing exports through schemes like PLI. Below are some of the main reasons behind this rapid growth:
Sustainable Manufacturing
Sustainable medicine manufacturing simply means – fulfilling the health needs while also taking care of the environment. Nowadays Indian pharmaceutical companies are also adopting eco-friendly methods – like minimizing waste, using energy-efficient technology, and focusing on pollution control. This is not only good for the environment but also keeps the production cost manageable in the long run.
Digital Transformation
Digital transformation in the pharma industry means using modern technology in production, supply chain, and quality control. Nowadays Indian companies are installing tools like automation, AI systems, and digital tracking. This not only increases the safety and speed of medicine, but also makes the entire process more transparent – which helps a lot in maintaining global standards.
Global Partnership
Global partnerships give Indian pharmaceutical companies entry into international markets and also enable technology sharing. Collaborations with global firms help in research, innovation, and regulatory approvals. These partnerships increase India’s credibility and the network of exports becomes even stronger.
What Is the Future Plan?
India’s future plan is clear – to make pharma exports even stronger, environment-friendly and technology-based. The government is promoting those manufacturing units that are adopting green processes – like reducing pollution, waste control and using energy saving techniques. The PLI scheme has made it quite easy for companies to adopt clean technology, which is beneficial for both long-term growth and sustainability. At the same time, the use of AI based tracking systems, automation and quality monitoring tools is being promoted for digital transformation. India is also focusing on global trade partnerships to make market access and international approvals easier. All this together makes India a global pharma leader.
Conclusion
India’s pharma industry is rapidly becoming modern and eco friendly. With strong support from the government, digital tools, and global tie-ups, export quality is improving. In the coming times, India is on the way to becoming a trusted global hub of affordable, safe and world-class medicines.
